Form 4 for TMO Thermo Fisher Scientific
Accepted 2026-03-02 00:00:00 ET · period of report 2026-02-28 · accession 0000097745-26-000041 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2026-03-02 | 2026-02-28 | TMO | Shafer Michael D | EVP | F - Tax | $521.11 | -815.84 | 22.8K | -3% | -$425.1K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-02-28 | F | D | 97.98 | $521.11 | 23,274.82 | D | — | — | |
| 2 | Common | Common Stock | 2026-02-28 | F | D | 251.66 | $521.11 | 22,556.95 | D | — | — | |
| 3 | Common | Common Stock | 2026-02-28 | F | D | 466.20 | $521.11 | 22,808.61 | D | — | — |